OSI Systems Inc. (OSIS) Company Profile
OSI Systems, Inc., together with its subsidiaries, designs and manufactures electronic systems and components for homeland security, healthcare, defense, and aerospace markets worldwide. The company operates in three divisions: Security, Healthcare, and Optoelectronics and Manufacturing. The Security division provides security and inspection systems under the Rapiscan Systems name. Its products....More>>>
News about OSIS
More Health Care Catalysts to Watch For by the End of February
Generally speaking, companies that reside within the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But consider that with t...Read More>>>
Valeant: Generic Syprine Is Finally Here
Syprine. Source: webmd Teva (TEVA) recently announced the U.S. launch of Valeant's (VRX) Syprine which treats Wilson's Disease: Teva Pharmaceutical Industries Ltd. (OTCPK:TEVJF), (NYSE and TASE: TEVA) today announced the launch of generic version...Read More>>>
Is Celgene A Growth Or A Value Stock?
Celgene's Long-Lasting Underperformance If an average Joe invested $100 in Celgene's (NASDAQ:CELG) stock in 2015, he would have lost $17 now. At the same time, if he invested in the S&P 500 (SPY) or the Nasdaq Biotech ETF (IBB), he would have gai...Read More>>>
Reata Pharmaceuticals A Buy On Bardoxolene Data
Reata Pharmaceuticals (RETA) is a clinical-stage biotechnology company specializing in drugs that affect mitochondria-related diseases. Its lead candidate is for PAH (pulmonary arterial hypertension) resulting from connective tissue disease. Reata ca...Read More>>>
Minerva: Get Ahead Of The Rush?
As part of my ongoing series on companies that are marketing and/or researching antidepressant medications, I will now cover Minerva Neurosciences (NERV). Minerva is a developmental biotech with four compounds currently listed in their pipeline. Two ...Read More>>>